TALPHERA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
TALPHERA, INC. (TLPH) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $11.14 per share as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2026-08-12
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $11.14.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $13.81.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $17.06.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $18.18.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $11.14 10-Q · filed 2026-08-12 |
| 2026-03-31 | $13.81 10-Q · filed 2026-05-13 |
| 2025-12-31 | $17.06 10-K · filed 2026-03-23 |
| 2025-09-30 | $18.18 10-Q · filed 2025-11-12 |
| 2025-06-30 | $19.73 10-Q · filed 2025-08-14 |
| 2025-03-31 | $25.19 10-Q · filed 2025-05-14 |
| 2024-12-31 | $34.28 10-K · filed 2025-03-31 |
| 2024-09-30 | $38.67 10-Q · filed 2024-11-13 |
| 2024-06-30 | $41.16 10-Q · filed 2024-08-14 |
| 2024-03-31 | $42.63 10-Q · filed 2024-05-14 |
| 2023-12-31 | $53.69 10-K · filed 2024-03-06 |
| 2023-09-30 | $54.66 10-Q · filed 2023-11-14 |
| 2023-06-30 | $57.63 10-Q · filed 2023-08-10 |
| 2023-03-31 | $58.42 10-Q · filed 2023-05-10 |
| 2022-12-31 | $65.76 8-K · filed 2023-08-01 |
| 2022-09-30 | $66.40 10-Q · filed 2022-11-14 |
| 2022-06-30 | $3.31 10-Q · filed 2022-08-11 |
| 2022-03-31 | $3.36 10-Q · filed 2022-05-16 |
| 2021-12-31 | $3.42 10-K · filed 2022-03-10 |
| 2020-12-31 | $3.66 10-K · filed 2021-03-15 |
| 2019-12-31 | $3.90 10-K · filed 2020-03-16 |
| 2018-12-31 | $4.44 10-K · filed 2019-03-07 |
| 2017-12-31 | $5.11 10-K · filed 2018-03-09 |
| 2016-12-31 | $5.32 10-K · filed 2017-03-03 |
| 2015-12-31 | $5.14 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |